Latest Breaking News On - Lang schwarz - Page 3 : comparemela.com

The Cannabist Company Continues Virginia Expansion with the Opening of Cannabist Richmond

The Cannabist Company Continues Virginia Expansion with the Opening of Cannabist Richmond
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesCannabist richmondLang schwarzCannabist company holdings regsitered stockCannabist companyTriple sevenColumbia care

UiPath to Participate in the Mizuho Technology Conference 2024

10.06.2024 - UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced that Ashim Gupta, Chief Financial Officer, will participate in a fireside chat at the Mizuho Technology Conference 2024, to be held at the JW .

Lang schwarzFoundation of innovationUipath business automation platformUipath registered

FMG Selects Guidewire Cloud to Maximise Agility and Support Continued Growth

10.06.2024 - FMG and Guidewire (NYSE: GWRE) announced that FMG has selected Guidewire InsuranceSuite on Guidewire Cloud to power its core business. A Guidewire customer since 2012, FMG will be migrating its on-premise installation of InsuranceSuite to Guidewire .

New zealandLang schwarzAsia pacific geoffrey diragoGuidewire softwareGuidewire software stockGuidewire viceAsia pacific geoffrey

AeroVironment to Host 2024 Analyst and Investor Day in New York City on June 27

AeroVironment to Host 2024 Analyst and Investor Day in New York City on June 27
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesLang schwarzInvestor relationsAerovironment stock

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

07.06.2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with .

Lang schwarzGossamer bio incCompensation committee of gossamer board directorsGossamer bioCompensation committeeInducement incentive award planNasdaq listing ruleNasdaq global select marketGossamer bio stock